Christine S. Kim

Christine practices corporate and securities law, with an emphasis on public company representation and capital markets transactions. She represents public and private companies in a wide range of corporate and securities matters – including public offerings, Securities and Exchange Commission (SEC) reporting and compliance, private financings, and corporate governance. She also is co-chair of Cooley’s Asian Pacific Islander Attorney Affinity Group.

Christine’s representative transactions include advising:

• Structure Therapeutics in its $185 million initial public offering (IPO) and $300 million private investment in public equity (PIPE) transaction
• Genelux Corporation in its $17 million IPO
• Drata in its $200 million Series C financing
• Design Therapeutics in its $125 million Series B financing and $240 million IPO
• Immunome in its $230 million follow-on offering